Back

A new pathway to treat PAH targeted by the first activin signaling inhibitor (ASI)

31 August 2025 (15:23 - 15:31)
Organised by: Logo
Congress Presentation Part of: A new way to treat pulmonary arterial hypertension (PAH) that improves hemodynamics and right ventricular function Treatment Open Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Maria Pilar Escribano Subias

12th of October University Hospital, Madrid (Spain)

5 More presentations in this session

Presentation thumbnail
Welcome
Presentation thumbnail
Right ventricular (RV) function assessment in PAH: why do we care?
Professor V. Moles (Ann Arbor, US)
Presentation thumbnail
Clinical data into context: effect of sotatercept on right ventricular (RV) function and structure
Doctor A. Vaidya (Temple, US)
Presentation thumbnail
Considerations on clinical implications
Professor S. Rosenkranz (Cologne, DE)
Presentation thumbnail
Q&A
Professor S. Rosenkranz (Cologne, DE)

Access the full session

Session thumbnail
A new way to treat pulmonary arterial hypertension (PAH) that improves hemodynamics and right ventricular function
Video

The Event

Event poster

ESC Congress 2025

31 August 2025 15:23 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources